The Medicines and Healthcare products Regulatory Agency (MHRA) is the executive body responsible for the safety, quality, and efficacy of medical devices and pharmaceuticals in the United Kingdom. While the MHRA does not directly certify medical devices, it performs critical market surveillance and oversees the UK Approved Bodies that conduct conformity assessments. The MHRA operates the UK medical device vigilance system and has the statutory power to remove any unsafe device from the market. For manufacturers, the MHRA serves as the primary regulatory interface for device registration and compliance enforcement across England, Wales, and Scotland.
The UKCA (UK Conformity Assessment) mark is the specific product marking required for goods placed on the Great Britain market. It signifies that a medical device meets the essential safety and performance requirements established under national law. Understanding the scope of MHRA oversight is fundamental for global manufacturers to ensure that their products remain legally compliant throughout their entire market lifecycle in the United Kingdom.
The regulatory framework for medical devices in Great Britain is based on the Medical Devices Regulations 2002 (UK MDR 2002). This legislation originally integrated several European directives into UK law, including the Active Implantable Medical Devices Directive (90/385/EEC), the Medical Devices Directive (93/42/EEC), and the In Vitro Diagnostic Medical Devices Directive (98/79/EC). Following the UK's withdrawal from the European Union, these regulations were amended to create a standalone UKCA marking regime that remains aligned with the core principles of safety and performance found in the original directives.
Under UK MDR 2002, all medical devices and IVDs must satisfy rigorous conformity assessment procedures before they can be placed on the market. This involves the preparation of a comprehensive declaration of conformity and the maintenance of a technical file that demonstrates compliance with the essential requirements. All regulatory documentation, including labels and instructions for use, must be provided in English to ensure clarity for healthcare professionals and patients.
For manufacturers located outside the United Kingdom, appointing a UK Responsible Person (UKRP) is a mandatory legal requirement for market access. The UKRP acts as the authorized representative for the non-UK manufacturer and performs specific tasks related to the manufacturer's obligations.
The UKRP must provide written evidence of their formal appointment by the manufacturer. This legal mandate authorizes the UKRP to act on the manufacturer's behalf in all dealings with the MHRA. The appointment must be established before any device is registered or placed on the Great Britain market.
Beyond simple registration, the UKRP has extensive responsibilities. They must ensure that the declaration of conformity and technical documentation have been correctly drafted and that appropriate conformity assessment procedures have been followed. Upon request, the UKRP must provide the MHRA with all information and documentation necessary to demonstrate device compliance. Furthermore, they are required to cooperate with the MHRA on any preventive or corrective actions taken to mitigate risks posed by a device.
The UKRP serves as a critical link in the vigilance chain. They must immediately inform the manufacturer of any complaints or reports from healthcare professionals, patients, or users regarding suspected incidents related to the devices they represent. This ensures that the manufacturer can initiate appropriate investigations and corrective actions in a timely manner to maintain patient safety.
Compliance in the UK market also extends to the supply chain entities involved in the distribution of medical devices. While importers and distributors are not required to appoint a UKRP, they have specific notification and safety obligations.
If a UK importer is not the designated UKRP, they must inform the manufacturer or the UKRP of their intention to import devices. In such cases, the manufacturer or their UKRP is responsible for providing the MHRA with the specific details of the importer. This ensures full traceability of the devices as they enter the British healthcare system.
Importers and distributors are obligated to ensure that storage and transport conditions do not jeopardize the compliance of the device. They must verify that the device bears the correct UKCA or CE marking and that the labeling requirements are met. While the importer's name and address do not necessarily need to appear on the product label, they must maintain robust records to support field safety corrective actions if required.
Our standardized service process facilitates the efficient navigation of the UK regulatory environment to ensure your products meet the high standards of UK MDR 2002. We offer a comprehensive suite of solutions to manage your UKCA certification and market access:
If you are interested in our UKCA certification services and wish to secure your market position in the United Kingdom, please feel free to contact us.
We're open for any suggestion or just have a chat with us.
Tel: Email: WhatsAPP